Our generics alone make us cash flow positive if you removed R and D costs
What a great thing it would be if companies could exclude their expenses when reporting financials.. The Dow would be at 90,000!!
Our generics alone make us cash flow positive if you removed R and D costs
Fyi, remove R&D expenses, then remove value attributed to ELTPs pipeline of drugs, as they will not be furthered. Then youre left with a dink company with $12m revs with a large market cap it cant support. It cant even support it with Sequest